Literature DB >> 7236323

Association of myositis and myocarditis in progressive systemic sclerosis.

S G West, P J Killian, O J Lawless.   

Abstract

A retrospective review of 47 patients with progressive systemic sclerosis revealed a highly significant (P less than 0.001) association between myositis and myocarditis. Three patients developed clinically overt myocarditis as an early feature of their disease. These patients had an inflammatory myopathy indistinguishable from polymyositis. Despite an excellent clinical response to steroids, the late occurrence of life-threatening conduction system defects appeared while they were receiving therapy. Consequently, patients with progressive systemic sclerosis and myositis should be evaluated for a coexisting myocarditis. The findings in these patients lend further support to the concept of a generalized myopathic process among the connective tissue diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236323     DOI: 10.1002/art.1780240506

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.

Authors:  Julie J Paik; Fredrick M Wigley; Thomas E Lloyd; Andrea M Corse; Livia Casciola-Rosen; Ami A Shah; Francesco Boin; Laura K Hummers; Andrew L Mammen
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-10       Impact factor: 4.794

2.  Elevated baseline serum creatine kinase in Thai early systemic sclerosis patients is associated with high incidence of cardiopulmonary complications and poor survival: an inception cohort study.

Authors:  Suparaporn Wangkaew; Jirapath Intum; Narawudt Prasertwittayakij; Juntima Euathrongchit
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

Review 3.  [Inflammatory cardiac diseases by primary extracardial diseases].

Authors:  M Brehm; P Rellecke; B E Strauer
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

4.  Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms.

Authors:  Stefan Schanz; Jörg Henes; Anja Ulmer; Ina Kötter; Gerhard Fierlbeck; C D Claussen; Marius Horger
Journal:  Eur Radiol       Date:  2012-07-29       Impact factor: 5.315

5.  Clinical and laboratory features of scleroderma patients developing skeletal myopathy.

Authors:  Yoshihiro Mimura; Hironobu Ihn; Masatoshi Jinnin; Yoshihide Asano; Kenichi Yamane; Kunihiko Tamaki
Journal:  Clin Rheumatol       Date:  2004-08-20       Impact factor: 2.980

Review 6.  The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Authors:  Lesley Ann Saketkoo; Jeanette H Magnus; Mittie K Doyle
Journal:  Am J Med Sci       Date:  2014-01       Impact factor: 2.378

7.  Acute myocarditis associated with adenoviral infection in a patient with scleroderma.

Authors:  Magdalena Dziadzio; Andrea Giovagnoni; Giovanni Pomponio; Andrea Recanatini; Osmy Paci della Costanza; Aldo Manzin; Walter Casagrande; Armando Gabrielli
Journal:  Clin Rheumatol       Date:  2003-11-08       Impact factor: 2.980

Review 8.  Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Authors:  Ulrich A Walker; Philip J Clements; Yannick Allanore; Oliver Distler; Chester V Oddis; Dinesh Khanna; Daniel E Furst
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

9.  Myocardial gallium-67 citrate scintigraphy in patients with systemic sclerosis.

Authors:  J Gaál; I Hegedüs; K Dévényi; L Czirják
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

Review 10.  Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).

Authors:  Henrik Pettersson; Helene Alexanderson; Janet L Poole; Janos Varga; Malin Regardt; Anne-Marie Russell; Yasser Salam; Kelly Jensen; Jennifer Mansour; Tracy Frech; Carol Feghali-Bostwick; Cecília Varjú; Nancy Baldwin; Matty Heenan; Kim Fligelstone; Monica Holmner; Matthew R Lammi; Mary Beth Scholand; Lee Shapiro; Elizabeth R Volkmann; Lesley Ann Saketkoo
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-07-01       Impact factor: 4.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.